Research Report Identifies Deckers Outdoor, Navient, Phillips 66, BioMarin Pharmaceutical, McKesson, and Equity Residential with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

30-10-2018

NEW YORK, Oct. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Deckers Outdoor Corporation (NYSE:DECK), Navient Corporation (NASDAQ:NAVI), Phillips 66 (NYSE:PSX), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), McKesson Corporation (NYSE:MCK), and Equity Residential (NYSE:EQR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

DECK DOWNLOAD: https://MarketSourceResearch.com/register/?so=DECK
NAVI DOWNLOAD: https://MarketSourceResearch.com/register/?so=NAVI
PSX DOWNLOAD: https://MarketSourceResearch.com/register/?so=PSX
BMRN DOWNLOAD: https://MarketSourceResearch.com/register/?so=BMRN
MCK DOWNLOAD: https://MarketSourceResearch.com/register/?so=MCK
EQR DOWNLOAD: https://MarketSourceResearch.com/register/?so=EQR

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Deckers Outdoor Corporation (NYSE:DECK), Navient Corporation (NASDAQ:NAVI), Phillips 66 (NYSE:PSX), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), McKesson Corporation (NYSE:MCK), and Equity Residential (NYSE:EQR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

DECKERS OUTDOOR CORPORATION (DECK) REPORT OVERVIEW

Deckers Outdoor's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Deckers Outdoor reported revenue of $250.59MM vs $209.72MM (up 19.49%) and analysts estimated basic earnings per share -$1.00 vs -$1.32. For the twelve months ended March 31st, 2018 vs March 31st, 2017, Deckers Outdoor reported revenue of $1,903.34MM vs $1,790.15MM (up 6.32%) and analysts estimated basic earnings per share $3.60 vs $0.18 (up 1,900.00%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $4.97. The estimated EPS forecast for the next fiscal year is $7.32 and is expected to report on May 23rd, 2019.

To read the full Deckers Outdoor Corporation (DECK) report, download it here: https://MarketSourceResearch.com/register/?so=DECK

-----------------------------------------

NAVIENT CORPORATION (NAVI) REPORT OVERVIEW

Navient's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Navient reported interest income of $1,227.00MM vs $1,070.00MM (up 14.67%) and analysts estimated basic earnings per share $0.31 vs $0.40 (down 22.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Navient reported interest income of $4,383.00MM vs $4,146.00MM (up 5.72%) and analysts estimated basic earnings per share $1.06 vs $2.15 (down 50.70%). Analysts expect earnings to be released on January 22nd, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.43. The estimated EPS forecast for the next fiscal year is $2.00 and is expected to report on January 22nd, 2019.

To read the full Navient Corporation (NAVI) report, download it here: https://MarketSourceResearch.com/register/?so=NAVI

-----------------------------------------

PHILLIPS 66 (PSX) REPORT OVERVIEW

Phillips 66's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Phillips 66 reported revenue of $29,788.00MM vs $25,627.00MM (up 16.24%) and analysts estimated basic earnings per share $3.20 vs $1.60 (up 100.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Phillips 66 reported revenue of $102,354.00MM vs $84,279.00MM (up 21.45%) and analysts estimated basic earnings per share $9.90 vs $2.94 (up 236.73%). Analysts expect earnings to be released on February 1st, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $1.07. The estimated EPS forecast for the next fiscal year is $9.67 and is expected to report on February 1st, 2019.

To read the full Phillips 66 (PSX) report, download it here: https://MarketSourceResearch.com/register/?so=PSX

-----------------------------------------

BIOMARIN PHARMACEUTICAL INC. (BMRN) REPORT OVERVIEW

BioMarin Pharmaceutical's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, BioMarin Pharmaceutical reported revenue of $372.85MM vs $317.45MM (up 17.45%) and basic earnings per share -$0.09 vs -$0.21. For the twelve months ended December 31st, 2017 vs December 31st, 2016, BioMarin Pharmaceutical reported revenue of $1,313.65MM vs $1,116.85MM (up 17.62%) and analysts estimated basic earnings per share -$0.67 vs -$3.80. Analysts expect earnings to be released on February 28th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.30. The estimated EPS forecast for the next fiscal year is $0.56 and is expected to report on February 28th, 2019.

To read the full BioMarin Pharmaceutical Inc. (BMRN) report, download it here: https://MarketSourceResearch.com/register/?so=BMRN

-----------------------------------------

MCKESSON CORPORATION (MCK) REPORT OVERVIEW

McKesson's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, McKesson reported revenue of $53,075.00MM vs $52,061.00MM (up 1.95%) and analysts estimated basic earnings per share $2.52 vs $0.01 (up 25,100.00%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, McKesson reported revenue of $208,357.00MM vs $198,533.00MM (up 4.95%) and analysts estimated basic earnings per share $0.32 vs $22.95 (down 98.61%). Analysts expect earnings to be released on February 7th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $3.41. The estimated EPS forecast for the next fiscal year is $14.28 and is expected to report on May 23rd, 2019.

To read the full McKesson Corporation (MCK) report, download it here: https://MarketSourceResearch.com/register/?so=MCK

-----------------------------------------

EQUITY RESIDENTIAL (EQR) REPORT OVERVIEW

Equity Residential's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Equity Residential reported revenue of $639.81MM vs $612.48MM (up 4.46%) and analysts estimated basic earnings per share $0.31 vs $0.53 (down 41.51%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Equity Residential reported revenue of $2,471.41MM vs $2,425.80MM (up 1.88%) and analysts estimated basic earnings per share $1.64 vs $11.75 (down 86.04%). Analysts expect earnings to be released on January 29th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.83. The estimated EPS forecast for the next fiscal year is $3.38 and is expected to report on January 29th, 2019.

To read the full Equity Residential (EQR) report, download it here: https://MarketSourceResearch.com/register/?so=EQR

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Latest news
Related news
Related shares
Phillips 66
VOL 1,207,392
101.96 USD
0.04 / 0.04 %

BioMarin Pharmaceutical Inc
VOL 641,562
81.57 USD
-1.62 / -1.95 %

Navient Corporation
VOL 626,256
13.55 USD
-0.16 / -1.17 %

Equity Residential of Benefic
VOL 389,037
77.15 USD
-1.44 / -1.83 %

McKesson Corporation
VOL 276,269
138.90 USD
-0.78 / -0.56 %

Deckers Outdoor Corporation
VOL 71,723
174.24 USD
-2.14 / -1.21 %